A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population

NCT00965822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

293

Enrollment

INDUSTRY

Sponsor class

Conditions

Upper Respiratory Tract Infections

Interventions

OTHER: North American ginseng
OTHER: Placebo

Sponsor

Afexa Life Sciences Inc